The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
PD-L1 expression and TOP3A mutation as prognostic factors for adjuvant chemotherapy in triple negative breast cancer.
 
Xue Wang
No Relationships to Disclose
 
Peng Yuan
No Relationships to Disclose
 
Feng Du
No Relationships to Disclose
 
Lina Cui
Employment - 3D Medicines
 
Fangchao Zheng
No Relationships to Disclose
 
Jian Yue
No Relationships to Disclose
 
Bei Zhang
Employment - 3D Medicines
 
Jiayu Wang
No Relationships to Disclose
 
Ying Fan
No Relationships to Disclose
 
Fei Ma
No Relationships to Disclose
 
Binghe Xu
Speakers' Bureau - AstraZeneca; Eisai; Pfizer; Roche
Research Funding - Jiangsu Hengrui Medicine (Inst)